How Adar Poonawalla’s Serum Institute shot to fame after Covid vaccine rush

Vaccine manufacturer Serum Institute of India (SII) has become a familiar name in India and around the globe after the pandemic. With an overwhelming demand for its Covishield vaccines, the company is poised to report a substantial rise in profit in FY21 and FY22. Here is all you need to know.

Pune-based Serum Institute of India (SII), the world’s largest vaccine manufacturer, is likely to witness a record surge in profit as demand for Covid-19 vaccines grows rapidly in India and other parts of the world. SII, which obtained a license to manufacture and supply Oxford and AstraZeneca’s vaccine under the name Covishield, has received an overwhelming number of orders as the second wave of Covid-19 wrecks havoc in India.